Standards and Guidelines
The College of American Pathologists (CAP) has updated its evidence-based guideline for analytic validation of immunohistochemical (IHC) assays to provide increased accuracy and consistency in laboratory practices. Many of the...
HER2 IHC testing in the wake of the 2023 HER2 Breast Guideline Update Clinical Value, Classification & Scoring and the impact of the ASCO-CAP 2023 HER2 Breast Testing Guideline Update Over the past several months, the HER2/neu IHC...
Visiopharm and Boston Cell Standards Partnership: Solution combining first AI-Driven IHC Levey-Jennings software with first quantitative IHC reference materials will enable labs to meet proposed regulatory changes COPENHAGEN, Denmark &...
Visiopharm has announced preregistration for their USCAP 2022 seminar. AI-driven stain quality standardization of IHC Featuring Marilyn M. Bui, MD, Ph.D., Moffitt Cancer Center and Martin Kristensson, Visiopharm Wednesday, March 23rd,...
Tampa, Florida / GlobeNewswire – Digital pathology and cancer informatics provider Inspirata announced today that it has received U.S. Food and Drug Administration (FDA) clearance for its Dynamyx digital pathology software. This clearance...
Visiopharm, a world leader in AI-driven precision pathology software, today announced that its existing portfolio of diagnostic apps have all been certified under the new In Vitro Diagnostic Regulation (IVDR). The major difference between...
